Pfizer sees high demand for COVID-19 pill as profits jump

Pfizer executives said Tuesday they are confident of strong demand for the company's COVID-19 antiviral treatment amid easing pandemic rules as the big drugmaker reported another round of strong earnings.
Pfizer executives said Tuesday they are confident of strong demand for the company’s COVID-19 antiviral treatment amid easing pandemic rules as the big drugmaker reported another round of strong earnings.